Visit the Living With PBC YouTube page

What is PBC?

Not a real patient.

Primary biliary cholangitis (PBC)

  • Primary

    A disease that starts suddenly and without a clear cause

  • Biliary

    Related to or affecting the bile ducts in the liver

  • Cholangitis

    Inflammation of the bile ducts

PBC is a chronic, progressive autoimmune liver condition that affects the bile ducts in the liver. A long-term treatment plan that includes medicine to help slow the progression of PBC can help prevent serious health issues, including the need for a liver transplant.

We’ve created a glossary of common terms to help you understand more about this disease.

What happens as PBC worsens?

Your bile ducts play an important role in keeping your liver healthy. With PBC:

  1. Body attacks bile ducts causing bile acid buildup

    Your body begins attacking your bile ducts, causing a buildup of toxic bile acid (cholestasis)

  2. Inflammation &
    liver cell damage

    Cholestasis causes further inflammation and damage to the liver cells

  3. Liver scarring
    (fibrosis)

    Ongoing cell damage leads to harmful scarring (fibrosis), which can result in cirrhosis over time

  4. Cirrhosis &
    permanent damage

    Once you have cirrhosis, liver damage is mostly permanent and end-stage liver disease (transplant or death) is possible

You may have heard of cirrhosis caused by drinking alcohol, but the cirrhosis related to PBC is not due to drinking alcohol.

~6 in 10 people are diagnosed with PBC before symptoms appear

Diagnosis may come as a surprise

A PBC diagnosis can take a long time because it is a rare disease, so many healthcare providers may not check for it until they have ruled out more common conditions first. In fact, many people who have PBC get diagnosed because their liver shows signs of damage during routine liver testing.

Healthcare providers will look at some key markers for diagnosis:

  • Alkaline phosphatase (ALP). An abnormally high ALP level can be a sign of liver damage
  • Antimitochondrial antibodies (AMAs). It is critical to check for AMAs when PBC is suspected since they are proteins made by the immune system and their presence is a sign of PBC
  • Other PBC-specific immune system proteins, including anti-sp100 or anti-gp210, may be used if AMA is negative

Healthcare providers may also perform a liver biopsy to confirm a diagnosis of PBC and to find out the level of PBC progression. After diagnosis, noninvasive tests such as liver ultrasound or magnetic resonance imaging (MRI) scan can check if there is fibrosis.

Everyone experiences symptoms differently, if at all,
and the most common are:

  • Pruritus
    (itching of the skin)
  • Fatigue
    (feeling tired all over)
  • Dry eyes and mouth
  • Trouble remembering and concentrating

How much itching or fatigue you feel is not related to how far PBC has progressed or how well your treatment is working.

Looking for tips for managing pruritus and fatigue?

PBC is complex and can affect everyone differently

Many people with PBC are also balancing other autoimmune conditions

pie chart
  • Just PBC
  • 1 additional autoimmune condition
  • 2 or more additional autoimmune conditions

Autoimmune conditions commonly associated with PBC include:

  • Sjögren’s syndrome
  • CREST syndrome
  • Raynaud’s disease
  • Autoimmune thyroid disease
  • Rheumatoid arthritis
  • Celiac disease
  • Autoimmune hepatitis

Treating early can mean better outcomes

In some people, PBC can progress very quickly. Treatment may work best in people whose PBC is still in early stages. So, it’s important to speak to your healthcare team about starting the treatment that’s right for you and your unique needs.

When I attended my first meeting with the support group for PBC… that was the first time that I had ever seen anyone besides my father who had PBC.

—Wayne, living with PBC

You’re not alone in this journey

Get access to tools, resources, and other information, plus connect with other people living with PBC.

All participating parties, including patients, physicians, and experts, were compensated by Intercept Pharmaceuticals.

Close